Page last updated: 2024-08-21

quinazolines and Bone Loss, Osteoclastic

quinazolines has been researched along with Bone Loss, Osteoclastic in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's3 (25.00)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Lu, X; Luo, S; Pang, C; Qin, H; Wen, L; Zhu, B1
Fukuma, Y; Komaki, S; Nishishita, K; Okamoto, K; Sakai, E; Tsukuba, T1
Deng, Q; Li, B; Li, P; Liu, H; Liu, J; Wei, Z; Yan, J; Zhang, Z1
Dixon, SJ; Jirik, FR; Kashishian, A; Lannutti, BJ; Pereverzev, A; Puri, KD; Shugg, RP; Sims, SM; Steiner, BH; Tanabe, N; Thomson, A1
Barth, C; Massard, C; Vignot, S1
Andrew, D; De Felice, M; Escott, KJ; Holen, I; Lambert, D1
Bae, YC; Baek, MC; Ihn, HJ; Kim, JA; Park, EK; Shin, HI1
de Vries, TJ; Everts, V; Green, TP; James, N; Klein-Nulend, J; Mullender, MG; Semeins, CM; van Duin, MA1
Beck-Nielsen, H; Byrjalsen, I; Christiansen, C; Henriksen, K; Karsdal, MA; Larsen, LK; Madsen, AN; Nielsen, RH1
Hofbauer, LC; Khosla, S; Rachner, TD1
Nishio, M; Okano, Y1
Baba, A; Kawamura, N; Makino, H; Ohta, Y; Sohda, T; Taketomi, S1

Reviews

3 review(s) available for quinazolines and Bone Loss, Osteoclastic

ArticleYear
[Bone targeted therapies: new agents].
    Bulletin du cancer, 2013, Volume: 100, Issue:11

    Topics: Aniline Compounds; Benzodioxoles; Bone Density Conservation Agents; Bone Resorption; Cathepsin K; Dasatinib; Diphosphonates; Humans; Molecular Targeted Therapy; Nitriles; Parathyroid Hormone-Related Protein; Pyrimidines; Quinazolines; Quinolines; RANK Ligand; Receptors, Chemokine; src-Family Kinases; Thiazoles; Transforming Growth Factor beta1

2013
Osteoporosis: now and the future.
    Lancet (London, England), 2011, Apr-09, Volume: 377, Issue:9773

    Topics: Absorptiometry, Photon; Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzodioxoles; Biphenyl Compounds; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Remodeling; Bone Resorption; Calcium; Denosumab; Diphosphonates; Female; Genetic Markers; Humans; Intercellular Signaling Peptides and Proteins; Middle Aged; Osteoblasts; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quinazolines; Randomized Controlled Trials as Topic; RANK Ligand; Risk Assessment; Risk Factors; Vitamin D Deficiency; Wnt Proteins

2011
[Efficacy of gefitinib in treatment of lung cancer patients with bone metastasis].
    Clinical calcium, 2008, Volume: 18, Issue:4

    Topics: Alkaline Phosphatase; Antineoplastic Agents; Biomarkers; Bone Neoplasms; Bone Resorption; Collagen Type I; Female; Fractures, Spontaneous; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Osteogenesis; Peptide Fragments; Peptides; Procollagen; Quinazolines

2008

Other Studies

9 other study(ies) available for quinazolines and Bone Loss, Osteoclastic

ArticleYear
Sotrastaurin, a PKC inhibitor, attenuates RANKL-induced bone resorption and attenuates osteochondral pathologies associated with the development of OA.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:15

    Topics: Animals; Bone and Bones; Bone Resorption; Cartilage Diseases; Cartilage, Articular; Cattle; Cell Differentiation; Female; Male; Mice; Mice, Inbred C57BL; Osteoarthritis; Osteoclasts; Protein Kinase C; Pyrroles; Quinazolines; RANK Ligand; Signal Transduction

2020
Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor κ-B ligand-stimulated signalling pathways.
    Clinical and experimental pharmacology & physiology, 2018, Volume: 45, Issue:8

    Topics: Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Indole Alkaloids; Macrophage Colony-Stimulating Factor; Macrophages; Osteoclasts; Osteogenesis; Quinazolines; RANK Ligand; Signal Transduction

2018
Roles for HB-EGF in Mesenchymal Stromal Cell Proliferation and Differentiation During Skeletal Growth.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2019, Volume: 34, Issue:2

    Topics: Animals; Bone Resorption; Cell Differentiation; Cell Proliferation; Chondrocytes; Heparin-binding EGF-like Growth Factor; MAP Kinase Signaling System; Mesenchymal Stem Cells; Mice; Mice, Transgenic; Osteoblasts; Proto-Oncogene Proteins c-akt; Quinazolines; Skeleton; Smad Proteins; Tyrphostins

2019
Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption.
    The Journal of biological chemistry, 2013, Dec-06, Volume: 288, Issue:49

    Topics: Adenine; Androstadienes; Animals; Bone Resorption; Cell Survival; Chromones; Cytoskeleton; Indazoles; Isoenzymes; Morpholines; Osteoclasts; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinazolines; Rabbits; RANK Ligand; Rats; Sulfonamides; Wortmannin

2013
Effects of Src-kinase inhibition in cancer-induced bone pain.
    Molecular pain, 2016, Volume: 12

    Topics: Animals; Behavior, Animal; Benzodioxoles; Bone Neoplasms; Bone Remodeling; Bone Resorption; Cancer Pain; Disease Models, Animal; Hyperalgesia; Male; Neurons; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord; src-Family Kinases

2016
Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways.
    BMB reports, 2017, Volume: 50, Issue:3

    Topics: Afatinib; Animals; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Down-Regulation; ErbB Receptors; JNK Mitogen-Activated Protein Kinases; Macrophages; Mice; NF-kappa B; Osteoclasts; Phosphorylation; Quinazolines; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction

2017
The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
    Molecular cancer research : MCR, 2009, Volume: 7, Issue:4

    Topics: Actins; Animals; Benzodioxoles; Blotting, Western; Bone and Bones; Bone Resorption; Cell Adhesion; Cell Differentiation; Cell Movement; Cells, Cultured; Coculture Techniques; Female; Fetus; Humans; Leukocytes, Mononuclear; Mice; Organ Culture Techniques; Osteoclasts; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); Quinazolines; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skull

2009
A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
    European journal of pharmacology, 2009, Aug-15, Volume: 616, Issue:1-3

    Topics: Adipogenesis; Animals; Biomarkers; Blood Glucose; Body Weight; Bone and Bones; Bone Resorption; Diet; Glucose Tolerance Test; Hypoglycemic Agents; Lipid Metabolism; Magnetic Resonance Imaging; Male; Muscles; Obesity; Osteogenesis; Pioglitazone; PPAR alpha; Quinazolines; Rats; Thiazolidinediones; Water

2009
Studies on disease-modifying antirheumatic drugs: synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect.
    Journal of medicinal chemistry, 1996, Dec-20, Volume: 39, Issue:26

    Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Bone Resorption; Dinoprostone; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Male; Pregnancy; Quinazolines; Quinolines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Structure-Activity Relationship

1996